Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.88
(-5.06%)
CNY 4.88
(-5.06%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 548.76 Million CNY | -12.08% |
| 2022 | 624.13 Million CNY | -18.03% |
| 2021 | 761.42 Million CNY | -29.1% |
| 2020 | 1.07 Billion CNY | -21.16% |
| 2019 | 1.36 Billion CNY | -15.08% |
| 2018 | 1.6 Billion CNY | -4.45% |
| 2017 | 1.67 Billion CNY | 6.88% |
| 2016 | 1.57 Billion CNY | 3.07% |
| 2015 | 1.52 Billion CNY | 13.82% |
| 2014 | 1.33 Billion CNY | 3023.72% |
| 2013 | 42.86 Million CNY | -10.48% |
| 2012 | 47.88 Million CNY | -12.66% |
| 2011 | 54.82 Million CNY | 17.26% |
| 2010 | 46.75 Million CNY | -23.93% |
| 2009 | 61.45 Million CNY | 33.86% |
| 2008 | 45.9 Million CNY | 50.29% |
| 2007 | 30.54 Million CNY | -16.62% |
| 2006 | 36.63 Million CNY | 16.89% |
| 2005 | 31.34 Million CNY | -49.63% |
| 2004 | 62.21 Million CNY | 46.74% |
| 2003 | 42.4 Million CNY | 22.51% |
| 2002 | 34.6 Million CNY | 1.46% |
| 2001 | 34.1 Million CNY | 68.14% |
| 2000 | 20.28 Million CNY | 60.23% |
| 1999 | 12.66 Million CNY | 25.18% |
| 1998 | 10.11 Million CNY | 64.88% |
| 1997 | 6.13 Million CNY | -30.79% |
| 1996 | 8.86 Million CNY | 9.23% |
| 1995 | 8.11 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 72.83 Million CNY | 26.21% |
| 2024 Q1 | 57.7 Million CNY | -62.82% |
| 2024 Q3 | 51.73 Million CNY | -19.66% |
| 2023 Q2 | 147.56 Million CNY | 24.11% |
| 2023 Q4 | 155.22 Million CNY | 22.15% |
| 2023 Q1 | 118.89 Million CNY | -40.84% |
| 2023 FY | 548.76 Million CNY | -12.08% |
| 2023 Q3 | 127.08 Million CNY | -13.88% |
| 2022 Q1 | 116.69 Million CNY | -61.48% |
| 2022 Q2 | 152.55 Million CNY | 30.73% |
| 2022 Q3 | 153.89 Million CNY | 0.88% |
| 2022 FY | 624.13 Million CNY | -18.03% |
| 2022 Q4 | 200.98 Million CNY | 30.6% |
| 2021 Q3 | 191.84 Million CNY | 25.95% |
| 2021 Q4 | 302.94 Million CNY | 57.91% |
| 2021 FY | 761.42 Million CNY | -29.1% |
| 2021 Q1 | 114.31 Million CNY | -75.37% |
| 2021 Q2 | 152.31 Million CNY | 33.24% |
| 2020 Q3 | 277.87 Million CNY | 50.9% |
| 2020 FY | 1.07 Billion CNY | -21.16% |
| 2020 Q1 | 147.81 Million CNY | -72.86% |
| 2020 Q2 | 184.14 Million CNY | 24.58% |
| 2020 Q4 | 464.14 Million CNY | 67.04% |
| 2019 Q2 | 189.01 Million CNY | -7.54% |
| 2019 FY | 1.36 Billion CNY | -15.08% |
| 2019 Q4 | 544.62 Million CNY | 28.39% |
| 2019 Q3 | 424.17 Million CNY | 124.42% |
| 2019 Q1 | 204.42 Million CNY | -72.48% |
| 2018 Q4 | 742.87 Million CNY | 149.1% |
| 2018 Q1 | 202.67 Million CNY | -77.54% |
| 2018 Q3 | 298.22 Million CNY | -17.25% |
| 2018 FY | 1.6 Billion CNY | -4.45% |
| 2018 Q2 | 360.39 Million CNY | 77.81% |
| 2017 Q2 | 330.02 Million CNY | 70.18% |
| 2017 FY | 1.67 Billion CNY | 6.88% |
| 2017 Q1 | 193.92 Million CNY | -73.4% |
| 2017 Q4 | 902.48 Million CNY | 239.97% |
| 2017 Q3 | 265.45 Million CNY | -19.57% |
| 2016 FY | 1.57 Billion CNY | 3.07% |
| 2016 Q2 | 338.86 Million CNY | 39.41% |
| 2016 Q4 | 729.06 Million CNY | 180.57% |
| 2016 Q1 | 243.06 Million CNY | -59.74% |
| 2016 Q3 | 259.84 Million CNY | -23.32% |
| 2015 Q1 | 213.01 Million CNY | -83.72% |
| 2015 Q3 | 306.41 Million CNY | -23.55% |
| 2015 Q4 | 603.75 Million CNY | 97.04% |
| 2015 FY | 1.52 Billion CNY | 13.82% |
| 2015 Q2 | 400.81 Million CNY | 88.16% |
| 2014 Q2 | 13.17 Million CNY | 31.5% |
| 2014 FY | 1.33 Billion CNY | 3023.72% |
| 2014 Q4 | 1.3 Billion CNY | 18963.4% |
| 2014 Q3 | 6.86 Million CNY | -47.89% |
| 2014 Q1 | 10.01 Million CNY | -33.7% |
| 2013 Q1 | 8.64 Million CNY | -49.96% |
| 2013 Q3 | 5.73 Million CNY | -57.05% |
| 2013 FY | 42.86 Million CNY | -10.48% |
| 2013 Q4 | 15.11 Million CNY | 163.3% |
| 2013 Q2 | 13.36 Million CNY | 54.52% |
| 2012 Q3 | 9.86 Million CNY | -6.87% |
| 2012 FY | 47.88 Million CNY | -12.66% |
| 2012 Q2 | 10.59 Million CNY | 4.4% |
| 2012 Q1 | 10.14 Million CNY | -48.29% |
| 2012 Q4 | 17.28 Million CNY | 75.24% |
| 2011 Q1 | 12.07 Million CNY | -20.64% |
| 2011 Q2 | 11.34 Million CNY | -6.03% |
| 2011 Q3 | 11.78 Million CNY | 3.85% |
| 2011 FY | 54.82 Million CNY | 17.26% |
| 2011 Q4 | 19.61 Million CNY | 66.47% |
| 2010 Q4 | 15.21 Million CNY | 37.25% |
| 2010 FY | 46.75 Million CNY | -23.93% |
| 2010 Q2 | 8.87 Million CNY | -23.33% |
| 2010 Q1 | 11.57 Million CNY | -45.7% |
| 2010 Q3 | 11.08 Million CNY | 24.92% |
| 2009 Q3 | 13.97 Million CNY | 24.04% |
| 2009 FY | 61.45 Million CNY | 33.86% |
| 2009 Q2 | 11.26 Million CNY | -24.43% |
| 2009 Q1 | 14.9 Million CNY | 1.44% |
| 2009 Q4 | 21.31 Million CNY | 52.59% |
| 2008 FY | 45.9 Million CNY | 50.29% |
| 2008 Q3 | 3.46 Million CNY | -82.56% |
| 2008 Q2 | 19.87 Million CNY | 152.41% |
| 2008 Q4 | 14.69 Million CNY | 323.81% |
| 2008 Q1 | 7.87 Million CNY | -38.67% |
| 2007 Q3 | 5.45 Million CNY | -19.74% |
| 2007 Q1 | 5.44 Million CNY | -67.67% |
| 2007 Q4 | 12.83 Million CNY | 135.19% |
| 2007 FY | 30.54 Million CNY | -16.62% |
| 2007 Q2 | 6.8 Million CNY | 24.91% |
| 2006 Q4 | 16.84 Million CNY | 224.0% |
| 2006 Q2 | 7.6 Million CNY | 8.97% |
| 2006 Q1 | 6.98 Million CNY | -55.29% |
| 2006 FY | 36.63 Million CNY | 16.89% |
| 2006 Q3 | 5.19 Million CNY | -31.68% |
| 2005 Q2 | 866.83 Thousand CNY | -88.96% |
| 2005 Q3 | 7 Million CNY | 707.56% |
| 2005 FY | 31.34 Million CNY | -49.63% |
| 2005 Q4 | 15.61 Million CNY | 123.13% |
| 2005 Q1 | 7.85 Million CNY | -80.13% |
| 2004 Q3 | 10.63 Million CNY | 83.78% |
| 2004 Q1 | 6.26 Million CNY | -70.32% |
| 2004 Q2 | 5.78 Million CNY | -7.61% |
| 2004 Q4 | 39.53 Million CNY | 271.81% |
| 2004 FY | 62.21 Million CNY | 46.74% |
| 2003 Q1 | 7.9 Million CNY | -46.2% |
| 2003 FY | 42.4 Million CNY | 22.51% |
| 2003 Q4 | 21.1 Million CNY | 258.22% |
| 2003 Q3 | 5.89 Million CNY | -21.47% |
| 2003 Q2 | 7.5 Million CNY | -5.15% |
| 2002 Q1 | 6.25 Million CNY | 0.0% |
| 2002 FY | 34.6 Million CNY | 1.46% |
| 2002 Q4 | 14.69 Million CNY | 85.15% |
| 2002 Q3 | 7.93 Million CNY | 38.93% |
| 2002 Q2 | 5.71 Million CNY | -8.66% |
| 2001 FY | 34.1 Million CNY | 68.14% |
| 2000 FY | 20.28 Million CNY | 60.23% |
| 1999 FY | 12.66 Million CNY | 25.18% |
| 1998 FY | 10.11 Million CNY | 64.88% |
| 1997 FY | 6.13 Million CNY | -30.79% |
| 1996 FY | 8.86 Million CNY | 9.23% |
| 1995 FY | 8.11 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.36 Billion CNY | 59.767% |
| Zhejiang Zhenyuan Share Co., Ltd. | 654.18 Million CNY | 16.114% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 343.25 Million CNY | -59.873% |
| Yifan Pharmaceutical Co., Ltd. | 2.82 Billion CNY | 80.601% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 307.2 Million CNY | -78.633% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.5 Billion CNY | 92.692% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 564.68 Million CNY | 2.819% |
| Boai NKY Medical Holdings Ltd. | 309.15 Million CNY | -77.508% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 463.02 Million CNY | -18.517% |